Who owns VINCERA PHARMA INC?
- Ticker: VINC
- CUSIP Number: 92731l106
Tip: Access positions for across all investors
Analyze quarterly positions in Vincera Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vincera Pharma stock
Who bought or sold VINCERA PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sage Rhino Capital | 1.7M | $8.6M | 0% | Mar 2024 |
|
| Octagon Capital Advisors | 1.0M | $5.1M | 100% | Mar 2024 |
|
| Point72 Asset Management | 955k | $4.8M | 177% | Mar 2024 |
|
| Rock Springs Capital Management | 892k | $4.5M | 0% | Mar 2024 |
|
| Bank of America Corporation | 701k | $3.5M | -35% | Mar 2024 |
|
| Vanguard Group | 667k | $3.4M | 30% | Mar 2024 |
|
| Goldman Sachs Group | 632k | $3.2M | -63% | Mar 2024 |
|
| Kingdon Capital Management | 385k | $1.9M | 0% | Mar 2024 |
|
| ExodusPoint Capital Management | 317k | $1.6M | -19% | Mar 2024 |
|
| Geode Capital Management | 183k | $924k | 18% | Mar 2024 |
|
| Citadel Advisors | 178k | $902k | -10% | Mar 2024 |
|
| Rubric Capital Management | 117k | $591k | -67% | Mar 2024 |
|
| Sio Capital Management | 102k | $516k | 0% | Mar 2024 |
|
| Marshall Wace | 72k | $362k | 100% | Mar 2024 |
|
| BlackRock | 47k | $238k | -27% | Mar 2024 |
|
| Northern Trust | 34k | $174k | 34% | Mar 2024 |
|
| T. Rowe Price Associates | 30k | $152k | -25% | Mar 2024 |
|
| Jane Street | 29k | $148k | 100% | Mar 2024 |
|
| Millennium Management | 26k | $131k | -25% | Mar 2024 |
|
| Woodline Partners | 24k | $120k | 100% | Mar 2024 |
|
| Morgan Stanley | 20k | $99k | -21% | Mar 2024 |
|
| Vontobel Holding | 15k | $76k | 100% | Mar 2024 |
|
| LPL Financial | 14k | $70k | 100% | Mar 2024 |
|
| American Century Companies | 12k | $60k | 100% | Mar 2024 |
|
| Colony | 11k | $10k | 100% | Mar 2024 |
|
| GW & Wade | 11k | $13k | 0% | Dec 2023 |
|
| LMR Partners | 10k | $51k | 0% | Mar 2024 |
|
| Acadian Asset Management | 5.3k | $26k | -87% | Mar 2024 |
|
| Tower Research Capital | 4.5k | $23k | -37% | Mar 2024 |
|
| UBS Group | 2.5k | $13k | -15% | Mar 2024 |
|
| Qube Research & Technologies | 2.5k | $13k | 61825% | Mar 2024 |
|
| ICA Group Wealth Management | 300.00 | $1.5k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 160.00 | $812.800000 | 20% | Mar 2024 |
|
| Barclays | 23.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Vincera Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Long Focus Capital Management | Dec 2023 | 1.1M | $1.3M |
| Tejara Capital | Dec 2023 | 233k | $275k |
| Walleye Trading Advisors | Dec 2023 | 115k | $136k |
| Schonfeld Strategic Advisors | Dec 2023 | 114k | $135k |
| XTX Topco | Sep 2023 | 17k | $17k |